Merve Tatlı
Embryologist
Merve Tatlı built her academic foundation in Biology at Istanbul University, before advancing into the field of Histology and Embryology with a Master’s degree from Dokuz Eylül University (2018) and later a PhD from İzmir Katip Çelebi University (2025).
She began her career as an intern in IVF and genetics laboratories at Memorial Hospital and Medical Park Hospital, later continuing her practical laboratory work as an independent researcher in Izmir. As a TÜBİTAK-funded PhD student, she also conducted research at Copenhagen University Hospital.
Her expertise includes tissue engineering, regenerative medicine, immunohistochemical staining techniques, and cell culture in the field of histology and embryology.
– Role of p38 MAPK, Akt and NFkB in renoprotective effects of nebivolol on renal ischemia-reperfusion injury in rats. Biotechnic & Histochemistry, 2023.
– Paricalcitol pretreatment attenuates renal ischemia/reperfusion injury by inhibiting p38 MAPK and activating PI3K/Akt signaling pathways. Turk J Biochem, 2019.
Poster Presentations:
– Histological evaluation of the effects of Apocynin on testicular damage induced by radiation – 14th National Histology and Embryology Congress, 2018.
– Correlation between in situ expression and circulating levels of miR-371a-3p in relation to primary diagnosis of germ cell tumors – Copenhagen Endocrine Disruptors Workshop, 2024.
Education :
– İzmir Katip Çelebi University, PhD in Histology and Embryology 2019–2025
– Dokuz Eylül University, MSc in Histology and Embryology 2015–2018
– Istanbul University, BSc in Biology 2010–2014
